Estrogen upregulation of BRCA1 expression with no effect on localization

Molecular Carcinogenesis

Volumn 22, Issue 2, 1998, Pages 102-109

  Romagnolo, Donato ^a,b   Annab, Lois A ^a   Thompson, Tracy E ^a   Risinger, John I ^a   Terry, Lori A ^a   Barrett, J Carl ^a   Afshari, Cynthia A ^a  

^a NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^b UNIVERSITY OF ARIZONA   (United States)

Author keywords

BRCA1; Breast cancer; Hormone; Ovarian cancer

Indexed keywords

ANTIESTROGEN; ESTROGEN; ESTROGEN RECEPTOR; FULVESTRANT; MESSENGER RNA; ONCOPROTEIN;

ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CELL PROLIFERATION; CONTROLLED STUDY; GENE EXPRESSION; GENETIC SUSCEPTIBILITY; HUMAN; HUMAN CELL; OVARY CANCER; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PROTEIN SECRETION;

ANTINEOPLASTIC AGENTS; BRCA1 PROTEIN; BREAST NEOPLASMS; CELL DIVISION; ESTRADIOL; ESTROGEN ANTAGONISTS; ESTROGENS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; NEOPLASMS, HORMONE-DEPENDENT; OVARIAN NEOPLASMS; RECEPTORS, ESTROGEN; RNA, MESSENGER; STIMULATION, CHEMICAL; TUMOR CELLS, CULTURED; UP-REGULATION;

EID: 0031806108     PISSN: 08991987     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2744(199806)22:2<102::AID-MC5>3.0.CO;2-O     Document Type: Article

References (46)

1. Topper YJ, Freeman CS. Multiple hormone interactions in the developmental biology of the mammary gland. Physiol Rev 60:1049-1060, 1980.
2. Nandi S, Guzman RC, Yang J. Hormones and mammary carcinogenesis in mice, rats, and humans: A unifying hypothesis. Proc Natl Acad Sci USA 92:3650-3657, 1995.
3. Rao BR, Slotman BJ. Endocrine factors in common epithelial ovarian cancer. Endocr Rev 12:14-26, 1991.
4. Forsyth IA. Mammary development. Proc Nutr Soc 48:17-22, 1989.
5. King M-C, Rowell S, Love SM. Inherited breast and ovarian cancer. What are the risks? What are the choices? JAMA 269:1975-1980, 1993.
6. Miki Y, Swensen J, Shattuck-Eidens D, et al. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 266:66-71, 1994.
7. Futreal PA, Liu Q, Shattuck-Eidens D, et al. BRCA1 mutations in primary breast and ovarian carcinomas. Science 266:120-122, 1994.
8. Lee JH, Kavanagh JJ, Wildrick DM, Wharton JT, Blick M. Frequent loss of heterozygosity on chromosomes 6q, 11, and 17 in human ovarian carcinomas. Cancer Res 50:2724-2728, 1990.
9. Eccles DM, Cranston G, Steel CM, Nakamura Y, Leonard RCF. Allele losses on chromosome 17 in human epithelial ovarian carcinoma. Oncogene 5:1599-1601, 1990.
10. Holt JT, Thompson ME, Szabo C, et al. Growth retardation and tumor inhibition by BRCA1. Nat Genet 12:298-302, 1996.
11. Shao N, Chai YL, Shyam E, Reddy P, Rao VN. Induction of apoptosis by the tumor suppressor protein BRCA1. Oncogene 13:1-7, 1996.
12. Wilson CA, Payton MN, Elliott GS, et al. Differential subcellular localization, expression and biological toxicity of BRCA1 and the splice variant BRCA1-Δ11b. Oncogene 14:1-16, 1997.
13. Easton DF, Bishop DT, Ford D, Crockford GP. Genetic linkage analysis in familial breast and ovarian cancer: Results from 214 families. Am J Hum Genet 52:678-701, 1993.
14. Castilla LH, Couch FJ, Edros MR, et al. Mutations in the BRCA1 gene in families with early-onset breast and ovarian cancer. Nat Genet 8:387-391, 1994.
15. Simard J, Tonin P, Durocher F, et al. Common origins of BRCA1 mutations in Canadian breast and ovarian cancer families. Nat Genet 8:392-398, 1994.
16. Struewing JP, Abeliovich D, Peretz T, et al. The carrier frequency of the BRCA1 185delAG mutation is approximately 1 percent in Ashkenazi Jewish individuals. Nat Genet 11:198-200, 1995.
17. Hosking L, Trowsdale JA. A somatic BRCA1 mutation in an ovarian tumour. Nat Genet 9:343-344, 1995.
18. Merajver SD, Pham TM, Caduff RF, et al. Somatic mutations in the BRCA1 gene in sporadic ovarian tumors. Nat Genet 9:439-450, 1995.
19. Thompson ME, Jensen RA, Obermiller PS, Page PS, Holt DL. Decreased expression of BRCA1 accelerates growth and is often present during sporadic breast cancer progression. Nat Genet 9:444-450, 1995.
20. Gudas JM, Nguyen H, Li T, Cowan KH. Hormone-dependent regulation of BRCA1 in human breast cancer cells. Cancer Res 55:4561-4565, 1995.
21. Marquis ST, Jayant VR, Wynshaw-Boris A, et al. The developmental pattern of BRCA1 expression implies a role in differentiation of the breast and other tissues. Nat Genet 11:17-26, 1995.
22. Marks JR, Huper G, Vaughn JP, et al. BRCA1 expression is not directly responsive to estrogen. Oncogene 14:115-121, 1997.
23. Spillman MA and Bowock AM. BRCA1 and BRCA2 mRNA levels are coordinately elevated in human breast cancer cells in response to estrogen. Oncogene 13:1639-1645, 1996.
24. Rao VN, Shao N, Ahmad M, Shyam E, Reddy P. Antisense RNA to the putative tumor suppressor gene BRCA1 transforms mouse fibroblasts. Oncogene 12:523-528, 1996.
25. Jensen RA, Thompson ME, Jetton TL, et al. BRCA1 is secreted and exhibits properties of a granin. Nat Genet 12:303-308, 1996.
26. Scully R, Ganesan S, Brown M, et al. Location of BRCA1 in human breast and ovarian cell lines. Science 272:123-125, 1996.
27. Chen Y, Chen C-F, Riley DJ, et al. Aberrant subcellular localization of BRCA1 in breast cancer. Science 270:789-791, 1995.
28. Wilson CA, Payton MN, Pekar SK, et al. BRCA1 protein products: Antibody specificity. Nat Genet 13:264-265, 1996.
29. Thomas JE, Smith M, Rubinfeld B, Gutowski M, Beckmann RP, Polakis P. Subcellular localization and analysis of apparent 180-kDa and 220-kDa proteins of the breast cancer susceptibility gene, BRCA1. J Biol Chem 271:28630-28635, 1996.
30. Aprelikova O, Kuthiala A, Bessho M, Ethier S, Liu E. BRCA1 protein level is not affected by peptide growth factors in MCF10A cell line. Oncogene 13:2487-2491, 1996.
31. Bienstock RJ, Darden T, Wiseman R, Pedersen L, Barrett JC. Molecular modeling of the amino-terminal zinc ring domain of BRCA1. Cancer Res 56:2539-2545, 1996.
32. Chapman MS, Verma IM. Transcriptional activation by BRCA1. Nature 382:678-679, 1996.
33. Monteiro ANA, August A, Hanafusa H. Evidence for a transcriptional activation function of BRCA1 C-terminal region. Proc Natl Acad Sci USA 93:13595-13599, 1996.
34. Soto AM, Sonnenschein C, Chung KL, Fernandez MF, Olea N, Serrano FO. The E-SCREEN assay as a tool to identify estrogens: An update on estrogenic environmental pollutants. Environ Health Perspect 103:113-122, 1995.
35. Berthois Y, Katzenellenbogen JA, Katzenellenbogen BS. Phenol red in tissue culture media is a weak estrogen: Implications concerning the study of estrogen-responsive cells in culture. Proc Natl Acad Sci USA 83:2496-2500, 1986.
36. Puissant C, Houdebine LM. An improvement of the single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Biotechniques 8:148-149, 1990.
37. Haendler B, Hofer E. Characterization of the human cyclophilin gene and of related processed pseudogenes. Eur J Biochem 190:477-482, 1990.
38. Schreiber E, Matthias P, Muller MM, Schaffner. Eukaryotic expression vectors for the analysis of mutant proteins. Nucleic Acids Res 17:6418, 1989.
39. Zajchowski DA, Sager R. Induction of estrogen-regulated genes differs in immortal and tumorigenic human mammary epithelial cells expressing a recombinant estrogen receptor. Mol Endocrinol 5:1613-1623, 1991.
40. Thomas JE, Smith M, Tonkinson JL, Rubinfeld B, Polakis P. Induction of phosphorylation on BRCA1 during the cell cycle and after DNA damage. Cell Growth Differ 8:801-809, 1997.
41. Ruffner H, Verma IM. BRCA1 is a cell cycle-regulated nuclear phosphoprotein. Proc Natl Acad Sci USA 94:7138-7143, 1997.
42. Coene E, Van Oostveldt P, Willems K, van Emmelo J, De Potter CR. BRCA1 is localized in cytoplasmic tube-like invaginations in the nucleus. Nat Genet 16:122-124, 1997.
43. Scully R, Chen J, Ochs RL, et al. Dynamic changes of BRCA1 subnuclear location and phosphorylation state are initiated by DNA damage. Cell 90:1-20, 1997.
44. Reddy KB, Yee D, Hilsenbeck SG, Coffey RJ, Osborne CK. Inhibition of estrogen-induced breast cancer cell proliferation by reduction in autocrine transforming growth factor alpha expression. Cell Growth Differ 5:1275-1281, 1994.
45. Annab L, Lyon T, Solomon G, et al. Inhibition of endogenous BRCA1 by antisense in an ER positive ovarian cell line results in proliferation and protection from cell death during estrogen deprivation. Abstract. Proceedings of the American Association for Cancer Research 37:585, 1996.
46. Norris J, Fan D, Aleman C, et al. Identification of a new subclass of Alu DNA repeats which can function as estrogen receptor-dependent transcriptional enhancers. J Biol Chem 270:22777-22782, 1995.